| 1CL5 | A:; B: | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA |
| 1FB2 | A:; B: | STRUCTURE OF PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AT 1.95 |
| 1FV0 | A:; B: | FIRST STRUCTURAL EVIDENCE OF THE INHIBITION OF PHOSPHOLIPASE A2 BY ARISTOLOCHIC ACID: CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ARISTOLOCHIC ACID |
| 1JQ8 | A:; B: | DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE LEU-ALA-ILE-TYR-SER AT 2.0 RESOLUTION |
| 1JQ9 | A:; B: | CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE PHE-LEU-SER-TYR-LYS AT 1.8 RESOLUTION |
| 1KPM | A:; B: | FIRST STRUCTURAL EVIDENCE OF A SPECIFIC INHIBITION OF PHOSPHOLIPASE A2 BY VITAMIN E AND ITS IMPLICATIONS IN INFLAMMATION: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND VITAMIN E AT 1.8 A RESOLUTION. |
| 1OXL | A:; B: | INHIBITION OF PHOSPHOLIPASE A2 (PLA2) BY (2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)-ACETIC ACID (INDOLE): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 FROM RUSSELL'S VIPER AND INDOLE AT 1.8 RESOLUTION |
| 1OYF | A:; B: | CRYSTAL STRUCTURE OF RUSSELLES VIPER (DABOIA RUSSELLII PULCHELLA) PHOSPHOLIPASE A2 IN A COMPLEX WITH VENOM 6-METHYL HEPTANOL |
| 1Q6V | A: | FIRST CRYSTAL STRUCTURE OF A C49 MONOMER PLA2 FROM THE VENOM OF DABOIA RUSSELLI PULCHELLA AT 1.8 A RESOLUTION |
| 1Q7A | A: | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELL'S VIPER PHOSPHOLIPASE A2 AND AN ANTIINFLAMMATORY AGENT OXYPHENBUTAZONE AT 1.6A RESOLUTION |
| 1SKG | A: | STRUCTURE-BASED RATIONAL DRUG DESIGN: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A PENTAPEPTIDE VAL-ALA-PHE-ARG-SER |
| 1SQZ | A: | DESIGN OF SPECIFIC INHIBITORS OF PHOPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOPHOLIPASE A2 AND A DESIGNED PEPTIDE DEHYDRO-ILE-ALA-ARG-SER AT 1.2A RESOLUTION |
| 1SV3 | A: | STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND 4-METHOXYBENZOIC ACID AT 1.3A RESOLUTION. |
| 1SV9 | A: | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUPII PHOSPHOLIPASE A2 AND ANTI-INFLAMMATORY AGENT 2-[(2,6-DICHLOROPHENYL)AMINO] BENZENEACETIC ACID AT 2.7A RESOLUTION |
| 1SXK | A: | CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A NON-SPECIFIC ANTI-INFLAMMATORY AMINO SALICYLIC ACID AT 1.2 A RESOLUTION |
| 1TDV | A: | NON-SPECIFIC BINDING TO PHOSPHOLIPASE A2:CRYSTAL STRUCTURE OF THE COMPLEX OF PLA2 WITH A DESIGNED PEPTIDE TYR-TRP-ALA-ALA-ALA-ALA AT 1.7A RESOLUTION |
| 1TG1 | A: | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PHOSPHOLIPASE A2 AND A DESIGNED PEPTIDE INHIBITOR PHQ-LEU-VAL-ARG-TYR AT 1.2A RESOLUTION |
| 1TG4 | A: | DESIGN OF SPECIFIC INHIBITORS OF GROUPII PHOSPHOLIPASE A2(PLA2): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PLA2 AND DESIGNED PEPTIDE PHE-LEU-ALA-TYR-LYS AT 1.7A RESOLUTION |
| 1TGM | A: | CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND ASPIRIN AT 1.86 A RESOLUTION |
| 1TH6 | A: | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 IN COMPLEX WITH ATROPINE AT 1.23A RESOLUTION |
| 1TJ9 | A: | STRUCTURE OF THE COMPLEXED FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND A RATIONALLY DESIGNED TETRA PEPTIDE,VAL-ALA-ARG-SER AT 1.1A RESOLUTION |
| 1TJK | A: | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 WITH A DESIGNED PENTAPEPTIDE, PHE- LEU-SER- THR- LYS AT 1.2 A RESOLUTION |
| 1TK4 | A: | CRYSTAL STRUCTURE OF RUSSELLS VIPER PHOSPHOLIPASE A2 IN COMPLEX WITH A SPECIFICALLY DESIGNED TETRAPEPTIDE ALA-ILE-ARG-SER AT 1.1 A RESOLUTION |
| 1TP2 | A:; B: | CRYSTAL STRUCTURE OF THE COMPLEX OF GROUP II PHOSPHOLIPASEA2 DIMER WITH A FATTY ACID TRIDECANOIC ACID AT 2.4 A RESOLUTION |
| 2GNS | A:1-133 | DESIGN OF SPECIFIC PEPTIDE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II PHOSPHOLIPASE A2 AND A DESIGNED PENTAPEPTIDE ALA- LEU- VAL-TYR- LYS AT 2.3 A RESOLUTION |
| 3FO7 | A: | SIMULTANEOUS INHIBITION OF ANTI-COAGULATION AND INFLAMMATION: CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 COMPLEXED WITH INDOMETHACIN AT 1.4 A RESOLUTION REVEALS THE PRESENCE OF THE NEW COMMON LIGAND BINDING SITE |
| 3G8F | A: | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II PHOSPHOLIPASE A2 AND DESIGNED PEPTIDE INHIBITOR CARBOBENZOXY-DEHYDRO-VAL-ALA-ARG-SER AT 1.2 A RESOLUTION |
| 4EIX | A: | STRUCTURAL STUDIES OF THE TERNARY COMPLEX OF PHASPHOLIPASE A2 WITH NIMESULIDE AND INDOMETHACIN |
| 4HMB | A: | CRYSTAL STRUCTURE OF THE COMPLEX OF GROUP II PHOSPHOLIPASE A2 WITH A 3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL AT 2.21 A RESOLUTION |
)
)